Safety and Effectiveness of RZV in Adults ≥18 Years of Age with Systemic Lupus Erythematosus (SLE) or Multiple Sclerosis (MS)
October 18, 2023
Authors:
Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, Humana HealthCare, HealthPartners Institute, University of Pennsylvania, GlaxoSmithKline
